M F Cordeiro1, L Chang, K S Lim
1Department of Pathology & Glaucoma, Moorfields Eye Hospital, London, UK.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
New therapies targeting conjunctival scarring, including antimetabolites and monoclonal antibodies to TGF-beta, show promise for improving glaucoma surgery outcomes and minimizing complications.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: